DNO ASA
DNO ASA (DTNOF) Financial Performance & Income Statement Overview
Analyze DNO ASA (DTNOF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
DNO ASA (DTNOF) Income Statement & Financial Overview
Explore comprehensive income reports for DNO ASA DTNOF, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $187.60M | $176.70M | $170.50M | $136.90M |
| Cost of Revenue | $121.10M | $118.60M | $102.00M | $78.90M |
| Gross Profit | $66.50M | $58.10M | $68.50M | $58.00M |
| Gross Profit Ratio | $0.35 | $0.33 | $0.40 | $0.42 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $41.90M | $5.50M | $4.50M | $21.80M |
| Operating Expenses | $38.50M | $140.00M | $37.90M | $61.40M |
| Total Costs & Expenses | $159.60M | $258.60M | $139.90M | $140.10M |
| Interest Income | $9.40M | $9.00M | $17.60M | $6.00M |
| Interest Expense | $24.00M | $19.80M | $20.20M | $10.70M |
| Depreciation & Amortization | $51.10M | $48.90M | $41.40M | $44.10M |
| EBITDA | $90.80M | -$24.00M | $89.50M | $46.90M |
| EBITDA Ratio | $0.48 | -$0.14 | $0.52 | $0.34 |
| Operating Income | $28.00M | -$81.90M | $30.60M | -$3.20M |
| Operating Income Ratio | $0.15 | -$0.46 | $0.18 | -$0.02 |
| Other Income/Expenses (Net) | -$12.30M | -$10.80M | -$2.70M | -$4.70M |
| Income Before Tax | $15.70M | -$92.70M | $27.90M | -$7.90M |
| Income Before Tax Ratio | $0.08 | -$0.52 | $0.16 | -$0.06 |
| Income Tax Expense | $19.30M | $5.70M | $8.00M | -$42.40M |
| Net Income | -$3.60M | -$98.40M | $20.00M | $34.50M |
| Net Income Ratio | -$0.02 | -$0.56 | $0.12 | $0.25 |
| EPS | -$0.004 | -$0.10 | $0.02 | $0.04 |
| Diluted EPS | -$0.004 | -$0.10 | $0.02 | $0.04 |
| Weighted Avg Shares Outstanding | $975.00M | $975.02M | $975.02M | $975.02M |
| Weighted Avg Shares Outstanding (Diluted) | $975.00M | $975.00M | $975.00M | $975.00M |
Over the last four quarters, DNO ASA achieved steady financial progress, growing revenue from $136.90M in Q2 2024 to $187.60M in Q1 2025. Gross profit stayed firm with margins at 35% in Q1 2025 versus 42% in Q2 2024. Operating income totaled $28.00M in Q1 2025, maintaining a 15% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $90.80M. Net income rose to -$3.60M, with EPS at -$0.004. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan